Article

Between viral targets and differentially expressed genes in COVID-19: the sweet spot for therapeutic intervention.

2021-01-28

Abstract excerpt

<title>Abstract</title> <p>The COVID-19 pandemic is raging. It revealed the importance of rapid scientific advancement towards understanding and treating new diseases. To address this challenge, we adapt an explainable artificial intelligence algorithm for data fusion and utilize it on new omics data on viral-host interactions, human protein interactions, and drugs to better understand SARS-CoV-2 infection mechan...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f1610129-6ce2-5bcb-824b-3b57ff2e8ae8
DOI: 10.21203/rs.3.rs-152622/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Between viral targets and differentially expressed genes in COVID-19: the sweet spot for therapeutic intervention.DOI 10.21203/rs.3.rs-152622/v2Read

Genomic Biomarker Heterogeneities Between SARS-CoV-2 and COVID-19Semantic proximity Read

COVID-19: A Drug Repurposing and Biomarker Identification by Using Comprehensive Gene-Disease Associations through Protein-Protein Interaction Network AnalysisSemantic proximity Read

A comprehensive SARS-CoV-2-human protein-protein interactome network identifies pathobiology and host-targeting therapies for COVID-19Semantic proximity Read

Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: insights from machine learning and bioinformatics approachesSemantic proximity Read

Identifying potential drug targets and candidate drugs for COVID-19: biological networks and structural modeling approachesSemantic proximity Read

Using unsupervised learning algorithms to identify essential genes associated with SARS-CoV-2 as potential therapeutic targets for COVID-19Semantic proximity Read

In-silico discovery of common molecular signatures for which SARS-CoV-2 infections and lung diseases stimulate each other, and drug repurposingSemantic proximity Read

Impact of Comorbidity on Severity of Covid-19 Patients: A Network of Target Coding Genes PerspectiveSemantic proximity Read

Interactome of SARS-CoV-2 / nCoV19 modulated host proteins with computationally predicted PPIsSemantic proximity Read

Transcriptome and SARS-CoV-2 biological network directed analysis for better therapeutic developmentSemantic proximity Read

Prediction of severe adverse events, modes of action and drug treatments for COVID-19's complications.Semantic proximity Read

Molecular signatures in the progression of COVID-19 severitySemantic proximity Read